Literature DB >> 18535108

Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: a novel function of ETB1 receptors.

Jagadeesha K Dammanahalli1, Zhongjie Sun.   

Abstract

Endothelin (ET)-1 stimulates nicotinamide adenine dinucleotide phosphate (NADPH) oxidases and increases superoxide production in some cells such as vascular smooth muscle cells. Here, we reported that ET1 inhibited NADPH oxidase activity, superoxide generation, and cell proliferation in human abdominal aortic endothelial cells (HAAECs) via the ETB1-Pyk2-Rac1-Nox1 pathway. Superoxide production was determined by assessing ethidium fluorescence using flow cytometry in HAAECs exposed to ET1 (10-30 nm) at different time intervals. ET1 significantly decreased superoxide production in HAAECs in the presence of NG-nitro-L-arginine methyl ester, indicating that ET1 suppressed superoxide generation independent of nitric oxide synthase. ET1 significantly attenuated NADPH oxidase activity and cell proliferation, which could be abolished by silence of Nox1 gene, suggesting that ET1-induced inhibition of NADPH oxidase activity was mediated by Nox1. Furthermore, RNA interference silence of ETB1 receptors significantly increased NADPH oxidase activity, and blocked the inhibitory effect of ET1 on NADPH oxidase activity. Activation of ETB1 receptors by ET1 suppressed protein phosphorylation of pyk2 (Y402) and Rac1, suggesting that ET1 inhibited NADPH oxidase activity via ETB1-Pyk2-Rac1 pathway. Indeed, inhibition of Pyk2 by AG-17 abolished ET1-induced suppression of NADPH oxidase activity. ET1 also attenuated angiotensin II-induced activation of NADPH oxidase and cell proliferation. This study demonstrated, for the first time, that ET1, via ETB1, inhibited NADPH oxidase activity in HAAECs by suppressing the Pyk2-Rac1-Nox1 pathway. This finding reveals a novel function of ETB1 receptors in regulating endothelial NADPH oxidase activity, superoxide production, and cell proliferation, opening a new avenue for understanding the role of ETB1 receptors in protecting endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535108      PMCID: PMC2582923          DOI: 10.1210/en.2008-0199

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  39 in total

Review 1.  NO and angiogenesis.

Authors:  John P Cooke
Journal:  Atheroscler Suppl       Date:  2003-12       Impact factor: 3.235

2.  Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo.

Authors:  K Wingler; S Wünsch; R Kreutz; L Rothermund; M Paul; H H Schmidt
Journal:  Free Radic Biol Med       Date:  2001-12-01       Impact factor: 7.376

3.  ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species.

Authors:  S Wedgwood; R W Dettman; S M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-11       Impact factor: 5.464

4.  Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells.

Authors:  Jian-Mei Li; Ajay M Shah
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

5.  Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.

Authors:  Lixin Li; Gregory D Fink; Stephanie W Watts; Carrie A Northcott; James J Galligan; Patrick J Pagano; Alex F Chen
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

Review 6.  Endothelin in the perinatal circulation.

Authors:  Thérèse Perreault; Flavio Coceani
Journal:  Can J Physiol Pharmacol       Date:  2003-06       Impact factor: 2.273

Review 7.  Vascular NAD(P)H oxidases: specific features, expression, and regulation.

Authors:  Bernard Lassègue; Roza E Clempus
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-08       Impact factor: 3.619

8.  NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.

Authors:  Lixin Li; Stephanie W Watts; Amy K Banes; James J Galligan; Gregory D Fink; Alex F Chen
Journal:  Hypertension       Date:  2003-07-28       Impact factor: 10.190

9.  Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.

Authors:  Stephanie W Watts; Gregory D Fink; Carrie A Northcott; James J Galligan
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

10.  Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cells: a comparative study.

Authors:  Chiwaka Kimura; Masahiro Oike; Keizo Ohnaka; Yoshiaki Nose; Yushi Ito
Journal:  J Physiol       Date:  2003-11-14       Impact factor: 5.182

View more
  10 in total

1.  Normal IgG downregulates the intracellular superoxide level and attenuates migration and permeability in human aortic endothelial cells isolated from a hypertensive patient.

Authors:  Xiuqing Wang; Qianyu Wang; Zhongjie Sun
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

Review 2.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

3.  Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage.

Authors:  Yuhong Wang; Zhongjie Sun
Journal:  Hypertension       Date:  2009-07-27       Impact factor: 10.190

4.  Genetic interleukin-10 deficiency causes vascular remodeling via the upregulation of Nox1.

Authors:  Jagadeesha K Dammanahalli; Xiuqing Wang; Zhongjie Sun
Journal:  J Hypertens       Date:  2011-11       Impact factor: 4.844

5.  Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway.

Authors:  Yuhong Wang; Makoto Kuro-o; Zhongjie Sun
Journal:  Aging Cell       Date:  2012-02-22       Impact factor: 9.304

6.  Aging-related kidney damage is associated with a decrease in klotho expression and an increase in superoxide production.

Authors:  Zhong Zuo; Han Lei; Xiuqing Wang; Yuhong Wang; William Sonntag; Zhongjie Sun
Journal:  Age (Dordr)       Date:  2010-09-10

7.  Activation of SIRT1 Attenuates Klotho Deficiency-Induced Arterial Stiffness and Hypertension by Enhancing AMP-Activated Protein Kinase Activity.

Authors:  Diansa Gao; Zhong Zuo; Jing Tian; Quaisar Ali; Yi Lin; Han Lei; Zhongjie Sun
Journal:  Hypertension       Date:  2016-09-12       Impact factor: 10.190

8.  Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1.

Authors:  Brandi M Wynne; Chin-Wei Chiao; R Clinton Webb
Journal:  J Am Soc Hypertens       Date:  2009 Mar-Apr

9.  Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis.

Authors:  Tinazzi Elisa; Puccetti Antonio; Patuzzo Giuseppe; Barbieri Alessandro; Argentino Giuseppe; Confente Federico; Dolcino Marzia; Beri Ruggero; Marchi Giacomo; Ottria Andrea; Righetti Daniela; Rampudda Mariaelisa; Lunardi Claudio
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

10.  Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1.

Authors:  Sofiane Ouerd; Noureddine Idris-Khodja; Michelle Trindade; Nathanne S Ferreira; Olga Berillo; Suellen C Coelho; Mario F Neves; Karin A Jandeleit-Dahm; Pierre Paradis; Ernesto L Schiffrin
Journal:  Cardiovasc Res       Date:  2021-03-21       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.